Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The Genco Board Has a Responsibility to Deliver on its Commitments to Create Value for Shareholders Urges the Genco Board to Engage in Good Faith with Respect to Diana's Offer of $27.34 Per Share,...
-
Diana Shares Valued at $2.54 Per Share Based on Diana's Volume-Weighted Average Price for the 30 Days Ended on June 16, 2026 Revised Offer Reflects a 53% Premium to Genco's Undisturbed Share Price...
-
Raises Serious Questions About Governance Changes Designed to Benefit and Protect John Wobensmith Following His Appointment as Chairman Shareholders Have One Last Opportunity to Send a Clear Message...
-
Amid Growing Opposition from Shareholders, Genco Board Continues to Further Entrench Itself by Refusing to Rescind the Poison Pill Should Shareholders Vote Against the Poison Pill as Recommended by...
-
Shareholders Have a Critical Opportunity to Send a Strong Message to Genco’s Entrenched Board Significant Investor Support Emerging to Defeat Proposals to Ratify Genco's Poison Pill and Equity...
-
ISS Recommendation Cites Entrenchment Concerns While Diana's $24.80 Per Share All-Cash Offer is on the Table Glass Lewis Recognizes Diana as a "Serious and Committed Bidder" and Highlights Risks That...
-
Decision to Withdraw Four Nominees Reflects Diana's Commitment to Providing Shareholders an Opportunity to Affect Meaningful Change on the Genco Board Ismar and Cornell Bring a Fresh Perspective to...
-
Diana Has Consistently Offered Approximately 1.0x NAV Based on the Same Broker Valuation Source Genco Itself Used for Five Years Genco Has Now Moved the Goalposts by Adopting a New Methodology It...
-
Response Definitively Confirms the Genco Board Rejects Engagement in Meaningful Negotiations Despite Diana's Repeated Good Faith Efforts Following Third Rejection of Increasingly Compelling Offers,...
-
Details Why the Entrenched Genco Board Should Not Be Trusted to Act in Shareholders' Best Interests Contrasts Diana's Six Accomplished, Independent Nominees Against a Board That Has Spent Six Months...